Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of Revenue
Ratios

Creative Medical Technology Holdings (CELZ) Cost of Revenue (2017 - 2025)

Historic Cost of Revenue for Creative Medical Technology Holdings (CELZ) over the last 9 years, with Q1 2025 value amounting to $1200.0.

  • Creative Medical Technology Holdings' Cost of Revenue changed N/A to $1200.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $2400.0, marking a year-over-year decrease of 4545.45%. This contributed to the annual value of $4400.0 for FY2024, which is 2222.22% up from last year.
  • Creative Medical Technology Holdings' Cost of Revenue amounted to $1200.0 in Q1 2025.
  • In the past 5 years, Creative Medical Technology Holdings' Cost of Revenue ranged from a high of $39449.0 in Q4 2021 and a low of $1200.0 during Q4 2023
  • For the 5-year period, Creative Medical Technology Holdings' Cost of Revenue averaged around $7785.5, with its median value being $4000.0 (2021).
  • Its Cost of Revenue has fluctuated over the past 5 years, first surged by 39311.25% in 2021, then plummeted by 8555.1% in 2022.
  • Over the past 5 years, Creative Medical Technology Holdings' Cost of Revenue (Quarter) stood at $39449.0 in 2021, then crashed by 85.55% to $5700.0 in 2022, then crashed by 78.95% to $1200.0 in 2023, then changed by 0.0% to $1200.0 in 2024, then changed by 0.0% to $1200.0 in 2025.
  • Its Cost of Revenue was $1200.0 in Q1 2025, compared to $1200.0 in Q4 2024 and $3200.0 in Q2 2024.